China Resources Medical Holdings Co (HKSE:01515) Cash And Cash Equivalents : HK$1,400 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is China Resources Medical Holdings Co Cash And Cash Equivalents?

China Resources Medical Holdings Co's quarterly cash and cash equivalents increased from Dec. 2022 (HK$3,482.91 Mil) to Jun. 2023 (HK$4,378.78 Mil) but then stayed the same from Jun. 2023 (HK$4,378.78 Mil) to Dec. 2023 (HK$1,400.46 Mil).

China Resources Medical Holdings Co's annual cash and cash equivalents increased from Dec. 2021 (HK$2,845.73 Mil) to Dec. 2022 (HK$3,482.91 Mil) but then declined from Dec. 2022 (HK$3,482.91 Mil) to Dec. 2023 (HK$1,400.46 Mil).

China Resources Medical Holdings Co Cash And Cash Equivalents Historical Data

The historical data trend for China Resources Medical Holdings Co's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Medical Holdings Co Cash And Cash Equivalents Chart

China Resources Medical Holdings Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

2,232.42

3,202.29

2,845.73

3,482.91

1,400.46

China Resources Medical Holdings Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															2,845.73	2,746.99	3,482.91	4,378.78	1,400.46

China Resources Medical Holdings Co Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

China Resources Medical Holdings Co (HKSE:01515) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

China Resources Medical Holdings Co Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of China Resources Medical Holdings Co's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Medical Holdings Co (HKSE:01515) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Resources Medical Holdings Co Ltd (HKSE:01515) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

1PH:Germany

Address

No. 9, Fuyi Street, 14th Floor, Kunlun Center Office Building, Fengtai District, Beijing, CHN, 100069

Website

http://www.crmedical.hk

China Resources Medical Holdings Co Ltd provides a full spectrum of general healthcare services, hospital management services, and also group purchasing organization business and other derived business from hospitals in Mainland China. The group has three operating segments: Self-owned hospitals, IOT/operate-transfer, and Others. The self-owned hospitals segment which generates the majority of revenue is engaged in the provision of out-patient and in-patient services by the consolidated hospitals. IOT/operate-transfer hospitals segment engages in the provision of services to IOT hospitals and OT hospitals. Others segment engages in the provision of services to other kinds of clients.

China Resources Medical Holdings Co (HKSE:01515) Headlines

No Headlines